{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:33:04Z","timestamp":1785540784455,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The data concerning the association between dengue viruses (DV) infection and autoimmune diseases (ADs) remain unclear and are scarce. This nationwide population-based cohort study assessed the risk of ADs among patients with DV infection. We analyzed Taiwanese medical data from the Registry of the National Notifiable Disease Reporting System of Taiwan\u2019s Centers for Disease Control between 1998 and 2015 and identified patients with DV infection. From the entire general population data in the National Health Insurance Research Database, we randomly selected a comparison cohort that was individual matching by age, sex, residence, and index date. We analyzed the risk of ADs using a Cox proportional hazards regression model stratified by sex, age, and residence. We enrolled 29,365 patients with DV infection (50.68% men; mean age, 44.13\u00a0years) and 117,460 age-, sex-, and residence-matched controls in the present study. The incidence rates of organ-specific ADs were nonsignificantly higher in the DV cohort than in the non-DV control cohort. An approximately 70% lower risk of primary Sjogren syndrome (pSS) was evident in the DV cohort than in the non-DV control cohort with an adjusted hazard ratio of 0.30 (95% confidence interval 0.13\u20130.67) after adjusting for comorbidities in matched design. By contrast, the other systemic ADs were nonsignificantly lower in the DV cohort than in the non-DV control cohort. This nationwide long-term cohort study demonstrated that patients with DV infection had a lower risk of primary Sjogren syndrome than those without DV infection.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>This retrospective, longitudinal cohort observational study shows that patients with DV infection had a lower risk of pSS than those without DV infection.<\/jats:italic>\u2022 <jats:italic>The DV cohort had an approximately 70% lower risk of pSS than the control group, with a multivariate-adjusted HR of 0.30.<\/jats:italic>\u2022 <jats:italic>On the basis of this result, we contended that DV infection has a protective effect that reduces the risk of pSS.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s10067-020-05282-2","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T07:03:46Z","timestamp":1594796626000},"page":"537-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lower risk of primary Sjogren\u2019s syndrome in patients with dengue virus infection: a nationwide cohort study in Taiwan"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-2787","authenticated-orcid":false,"given":"Chi-Ching","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiou-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Wu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Huey","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"5282_CR1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"CP Simmons","year":"2012","unstructured":"Simmons CP, Farrar JJ, van Vinh Chau N, Wills B (2012) Dengue. N Engl J Med 366:1423\u20131432","journal-title":"N Engl J Med"},{"key":"5282_CR2","unstructured":"Dengue: Guidelines for diagnosis, treatment, prevention and control. New edition. World Health Organization; 2009"},{"key":"5282_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCC.0b013e3181e911a7","volume":"12","author":"S Ranjit","year":"2011","unstructured":"Ranjit S, Kissoon N (2011) Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 12:90\u2013100","journal-title":"Pediatr Crit Care Med"},{"key":"5282_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijid.2010.09.008","volume":"15","author":"G Garc\u00eda","year":"2011","unstructured":"Garc\u00eda G, Gonz\u00e1lez N, P\u00e9rez AB, Sierra B, Aguirre E, Rizo D et al (2011) Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 15:38\u201343","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5282_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfma.2012.11.006","volume":"112","author":"SW Wan","year":"2013","unstructured":"Wan SW, Lin CF, Yeh TM, Liu CC, Liu HS, Wang S, Ling P, Anderson R, Lei HY, Lin YS (2013) Autoimmunity in dengue pathogenesis. J Formos Med Assoc 112(1):3\u201311","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"5282_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/vim.2006.19.127","volume":"19","author":"CF Lin","year":"2006","unstructured":"Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS (2006) Autoimmune pathogenesis in dengue virus infection. Viral Immunol 19(2):127\u2013132","journal-title":"Viral Immunol"},{"key":"5282_CR7","first-page":"9726e36","volume":"286","author":"IJ Liu","year":"2011","unstructured":"Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 286:9726e36","journal-title":"J Biol Chem"},{"key":"5282_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","volume":"51","author":"S Kivity","year":"2014","unstructured":"Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, Agmon-Levin N (2014) Infection and autoimmunity in Sjogren\u2019s syndrome: a clinical study and comprehensive review. J Autoimmun 51:17\u201322","journal-title":"J Autoimmun"},{"key":"5282_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-015-0306-7","volume":"13","author":"M Versini","year":"2015","unstructured":"Versini M, Jeandel PY, Bashi T, Bizzaro G, Blank M, Shoenfeld Y (2015) Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med 13:81","journal-title":"BMC Med"},{"issue":"4","key":"5282_CR10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","volume":"22","author":"BE Martina","year":"2009","unstructured":"Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22(4):564\u2013581","journal-title":"Clin Microbiol Rev"},{"key":"5282_CR11","first-page":"71","volume-title":"Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan","author":"TM Cheng","year":"2009","unstructured":"Cheng TM (2009) Taiwan\u2019s National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L (eds) Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. World Scientific, Hackensack, pp 71\u2013204"},{"key":"5282_CR12","doi-asserted-by":"crossref","first-page":"37817","DOI":"10.1038\/srep37817","volume":"6","author":"CC Chang","year":"2016","unstructured":"Chang CC, Chang YS, Chen WS, Chen YH, Chen JH (2016) Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study. Sci Rep 6:37817","journal-title":"Sci Rep"},{"issue":"8","key":"5282_CR13","doi-asserted-by":"crossref","first-page":"e0135187","DOI":"10.1371\/journal.pone.0135187","volume":"10","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chiou CS, Lin HL, Wang LH, Chang YS, Lin HC (2015) Increased risk of acute pancreatitis in patients with rheumatoid arthritis: a population-based cohort study. PLoS One 10(8):e0135187","journal-title":"PLoS One"},{"key":"5282_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1740-2557-5-1","volume":"5","author":"M Fridkis-Hareli","year":"2008","unstructured":"Fridkis-Hareli M (2008) Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis 5:1","journal-title":"J Autoimmune Dis"},{"key":"5282_CR15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"5282_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"5282_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"5282_CR18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sj\u00f6gren\u2019s Syndrome (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"5282_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"5282_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"5282_CR21","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet. 335:1078\u20131080","journal-title":"Lancet."},{"key":"5282_CR22","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"5282_CR23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"5282_CR24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129\u20131134","journal-title":"Arthritis Rheum"},{"key":"5282_CR25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jamainternmed.2015.3528","volume":"175","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, Zhang W, Doherty M (2015) Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med 175:1518\u20131526","journal-title":"JAMA Intern Med"},{"key":"5282_CR26","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","volume":"67","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, Zhang W, Doherty M (2015) Familial risk of Sj\u00f6gren\u2019s syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis Rheumatol 67:1904\u20131912","journal-title":"Arthritis Rheumatol"},{"key":"5282_CR27","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1128\/JVI.76.23.12097-12111.2002","volume":"76","author":"S Tracy","year":"2002","unstructured":"Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS (2002) Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097\u201312111","journal-title":"J Virol"},{"key":"5282_CR28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0798-781","volume":"4","author":"MS Horwitz","year":"1998","unstructured":"Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998) Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781\u2013785","journal-title":"Nat Med"},{"key":"5282_CR29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI17005","volume":"113","author":"U Christen","year":"2004","unstructured":"Christen U, Benke D, Wolfe T, Rodrigo E, Rhode A, Hughes AC, Oldstone MB, Von Herrath MG (2004) Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 113:74\u201384","journal-title":"J Clin Invest"},{"key":"5282_CR30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/eji.200323910","volume":"33","author":"P Zaccone","year":"2003","unstructured":"Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A (2003) Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33:1439\u20131449","journal-title":"Eur J Immunol"},{"key":"5282_CR31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/76277","volume":"6","author":"MS Horwitz","year":"2000","unstructured":"Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N (2000) Pancreatic expression of interferon-_ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6:693\u2013697","journal-title":"Nat Med"},{"key":"5282_CR32","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1128\/JVI.76.23.12097-12111.2002","volume":"76","author":"S Tracy","year":"2002","unstructured":"Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS (2002) Toward testing the hypothesis that group B coxsackie viruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097\u201312111","journal-title":"J Virol"},{"key":"5282_CR33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.87.3.968","volume":"87","author":"CO Jacob","year":"1990","unstructured":"Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-\u03b1and interleukin 1. Proc Natl Acad Sci U S A 87:968\u2013972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5282_CR34","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.4049\/jimmunol.166.12.7023","volume":"166","author":"U Christen","year":"2001","unstructured":"Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA, Flavell RA, von Herrath MG (2001) A dual role for TNF-\u03b1 in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166:7023\u20137032","journal-title":"J Immunol"},{"issue":"1","key":"5282_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","volume":"160","author":"H Okada","year":"2010","unstructured":"Okada H, Kuhn C, Feillet H, Bach JF (2010) The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update. Clin Exp Immunol 160(1):1\u20139","journal-title":"Clin Exp Immunol"},{"key":"5282_CR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20040298","volume":"200","author":"S Mendez","year":"2004","unstructured":"Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y (2004) Role for CD4_CD25_ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 200:201\u2013210","journal-title":"J Exp Med"},{"key":"5282_CR37","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","volume":"78","author":"FN Toka","year":"2004","unstructured":"Toka FN, Suvas S, Rouse BT (2004) CD4_CD25_ T cells regulate vaccinegenerated primary and memory CD8_ T-cell responses against herpes simplex virus type 1. J Virol 78:13082\u201313089","journal-title":"J Virol"},{"key":"5282_CR38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1074-7613(04)00054-8","volume":"20","author":"U Dittmer","year":"2004","unstructured":"Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S et al (2004) Functional impairment of CD8_ T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293\u2013303","journal-title":"Immunity"},{"key":"5282_CR39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","volume":"8","author":"K Murali-Krishna","year":"1998","unstructured":"Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177\u2013187","journal-title":"Immunity"},{"key":"5282_CR40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/90950","volume":"7","author":"D Homann","year":"2001","unstructured":"Homann D, Teyton L, Oldstone MB (2001) Differential regulation of antiviral T-cell immunity results in stable CD8_ but declining CD4_ T-cell memory. Nat Med 7:913\u2013919","journal-title":"Nat Med"},{"key":"5282_CR41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1084\/jem.171.6.2077","volume":"171","author":"MB Oldstone","year":"1990","unstructured":"Oldstone MB (1990) Viruses as therapeutic agents. I Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 171:2077\u20132089","journal-title":"J Exp Med"},{"key":"5282_CR42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.239.4839.500","volume":"239","author":"MB Oldstone","year":"1988","unstructured":"Oldstone MB (1988) Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 239:500\u2013502","journal-title":"Science"},{"key":"5282_CR43","first-page":"191","volume":"47","author":"MN Manoussakis","year":"2001","unstructured":"Manoussakis MN, Moutsopoulos HM (2001) Sjogren\u2019s syndrome: current concepts. Adv Intern Med 47:191\u2013217","journal-title":"Adv Intern Med"},{"key":"5282_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2002.tb02942.x","volume":"958","author":"RM Zinkernagel","year":"2002","unstructured":"Zinkernagel RM (2002) Antiinfection immunity and autoimmunity. Ann N Y Acad Sci 958:3\u20136","journal-title":"Ann N Y Acad Sci"},{"key":"5282_CR45","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.20463","volume":"50","author":"A Triantafyllopoulou","year":"2004","unstructured":"Triantafyllopoulou A, Tapinos N, Moutsopoulos HM (2004) Evidence for coxsackievirus infection in primary Sjogren\u2019s syndrome. Arthritis Rheum 50:2897\u20132902","journal-title":"Arthritis Rheum"},{"key":"5282_CR46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar3262","volume":"13","author":"NV Sipsas","year":"2011","unstructured":"Sipsas NV, Gamaletsou MN, Moutsopoulos HM (2011) Is Sj\u00f6gren\u2019s syndrome a retroviral disease? Arthritis Res Ther 13:212","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"5282_CR47","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.174.12.7481","volume":"174","author":"U Christen","year":"2005","unstructured":"Christen U, von Herrath MG (2005) Infections and autoimmunity--good or bad? J Immunol 174(12):7481\u20137486","journal-title":"J Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05282-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05282-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05282-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:17:48Z","timestamp":1626308268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05282-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5282"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05282-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}